Payments to Acquire Property, Plant, and Equipment of REGENXBIO Inc. from 31 Mar 2015 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
Summary
REGENXBIO Inc. annual and quarterly Payments to Acquire Property, Plant, and Equipment in USD history and change rate from 31 Mar 2015 to 31 Dec 2025.
  • REGENXBIO Inc. Payments to Acquire Property, Plant, and Equipment for the quarter ending 31 Mar 2025 was $1,024,000, a 84% increase year-over-year.
  • REGENXBIO Inc. annual Payments to Acquire Property, Plant, and Equipment for 2025 was $2,414,000, a 0.9% decline from 2024.
  • REGENXBIO Inc. annual Payments to Acquire Property, Plant, and Equipment for 2024 was $2,436,000, a 76% decline from 2023.
  • REGENXBIO Inc. annual Payments to Acquire Property, Plant, and Equipment for 2023 was $9,960,000, a 68% decline from 2022.
Source SEC data
View on sec.gov
Payments to Acquire Property, Plant, and Equipment, Annual (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Annual Change (%)
Payments to Acquire Property, Plant, and Equipment, Quarterly (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Quarterly Change (%)

REGENXBIO Inc. Annual Payments to Acquire Property, Plant, and Equipment (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $2,414,000 -$22,000 -0.9% 01 Jan 2025 31 Dec 2025 10-K 05 Mar 2026 2025 FY
2024 $2,436,000 -$7,524,000 -76% 01 Jan 2024 31 Dec 2024 10-K 05 Mar 2026 2025 FY
2023 $9,960,000 -$20,764,000 -68% 01 Jan 2023 31 Dec 2023 10-K 13 Mar 2025 2024 FY
2022 $30,724,000 -$53,451,000 -64% 01 Jan 2022 31 Dec 2022 10-K 13 Mar 2025 2024 FY
2021 $84,175,000 +$57,306,000 +213% 01 Jan 2021 31 Dec 2021 10-K 27 Feb 2024 2023 FY
2020 $26,869,000 +$15,149,000 +129% 01 Jan 2020 31 Dec 2020 10-K 28 Feb 2023 2022 FY
2019 $11,720,000 -$1,558,000 -12% 01 Jan 2019 31 Dec 2019 10-K 01 Mar 2022 2021 FY
2018 $13,278,000 +$6,118,000 +85% 01 Jan 2018 31 Dec 2018 10-K 01 Mar 2021 2020 FY
2017 $7,160,000 -$989,000 -12% 01 Jan 2017 31 Dec 2017 10-K 26 Feb 2020 2019 FY
2016 $8,149,000 +$7,627,000 +1461% 01 Jan 2016 31 Dec 2016 10-K 27 Feb 2019 2018 FY
2015 $522,000 01 Jan 2015 31 Dec 2015 10-K 06 Mar 2018 2017 FY

REGENXBIO Inc. Quarterly Payments to Acquire Property, Plant, and Equipment (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $1,024,000 +$467,000 +84% 01 Jan 2025 31 Mar 2025 10-Q 12 May 2025 2025 Q1
Q1 2024 $557,000 -$4,261,000 -88% 01 Jan 2024 31 Mar 2024 10-Q 12 May 2025 2025 Q1
Q1 2023 $4,818,000 -$6,149,000 -56% 01 Jan 2023 31 Mar 2023 10-Q 08 May 2024 2024 Q1
Q1 2022 $10,967,000 -$20,054,000 -65% 01 Jan 2022 31 Mar 2022 10-Q 03 May 2023 2023 Q1
Q1 2021 $31,021,000 +$26,391,000 +570% 01 Jan 2021 31 Mar 2021 10-Q 04 May 2022 2022 Q1
Q1 2020 $4,630,000 +$2,175,000 +89% 01 Jan 2020 31 Mar 2020 10-Q 05 May 2021 2021 Q1
Q1 2019 $2,455,000 +$111,000 +4.7% 01 Jan 2019 31 Mar 2019 10-Q 07 May 2020 2020 Q1
Q1 2018 $2,344,000 -$585,000 -20% 01 Jan 2018 31 Mar 2018 10-Q 07 May 2019 2019 Q1
Q1 2017 $2,929,000 +$2,513,000 +604% 01 Jan 2017 31 Mar 2017 10-Q 08 May 2018 2018 Q1
Q1 2016 $416,000 +$310,000 +292% 01 Jan 2016 31 Mar 2016 10-Q 09 May 2017 2017 Q1
Q1 2015 $106,000 01 Jan 2015 31 Mar 2015 10-Q 05 May 2016 2016 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.